Zimmer Biomet Gains FDA Clearance for Osseofit Stemless Shoulder Implant
Zimmer Biomet's Osseofit stemless shoulder implant receives FDA clearance, offering a bone-preserving solution for total shoulder replacements. Designed to match the humeral anatomy, the implant aims to enhance surgical outcomes and workflow efficiency, particularly in ambulatory surgery centers.
FDA Identifies New Safety Concerns for Ocaliva in Treating Rare Liver Disease
The FDA has reported additional safety risks linked to Ocaliva, a drug for primary biliary cholangitis, citing serious liver injuries in patients. This marks another setback for the drug, originally poised as a blockbuster.
GSK and Muna Therapeutics Partner to Target Alzheimer’s Treatment
GSK partners with Muna Therapeutics in a major collaboration to develop Alzheimer's treatments, marking a pivotal step in neurodegenerative disease research.
Global Concern Possible Over Rwanda’s Marburg Outbreak
A significant Marburg virus outbreak in Rwanda, with 27 cases and nine deaths, is raising global [...]
Medical Affairs Summit
The Medical Affairs Summit, scheduled for 24 – 25 October at the prestigious Encore Boston Harbor, [...]
Johnson & Johnson Nears Settlement in Talcum Powder Lawsuits with $7.6 Billion Offer
Johnson & Johnson (J&J) has increased its settlement offer to $7.6 billion, in an attempt to [...]
Medical Affairs Summit 2024
The Medical Affairs Summit, scheduled for 24 - 25 October at the prestigious Encore Boston Harbor, in Boston, MA, is [...]
Biden Administration’s Medicare Drug Price Negotiation Sparks Industry Backlash and Future Savings
The Biden Administration announced price reductions for ten selected drugs under the Medicare price negotiation program, [...]
Cardinal Health Opens Advanced Therapy Innovation Center in Tennessee
Cardinal Health has launched its Advanced Therapy Innovation Center in La Vergne, Tennessee, which expands its [...]
The Need for Evidence-Based Physician Education in the Era of Precision Medicine
With the increased interest and use of precision medicine, the importance of pre-market and ongoing physician [...]
Navigating the Complexities of Digital Personalization in Pharma
As personalization becomes standard in consumer engagement, the pharmaceutical industry faces increasing pressure to deliver tailored [...]
Strategies for Bridging Regulatory and Reimbursement Evidence Needs in MedTech
MedTech companies must navigate both regulatory approval and reimbursement processes to successfully bring products to market. [...]
Clarivate’s BioWorld™ Earns Nine 2024 APEX Awards for Publication Excellence
BioWorld™, a drug development news service provided by Clarivate Plc, has been honored with nine 2024 [...]
Healthcare’s Environmental Impact and Decarbonization Efforts
The healthcare sector is known to contribute to greenhouse gas emissions, accounting for nearly 9% of [...]
Medical Affairs Outsourcing Market Poised for Rapid Growth
The Global Medical Affairs Outsourcing Market is set for substantial growth, projected to expand at a [...]
HHS Allocates $500 Million to Navigators over 5 Years
Several key developments have impacted payers and the health insurance sector this June. The Department of [...]
PHTI Study Confirms Benefits of Physical Therapist-Guided Virtual MSK Solutions
A Peterson Health Technology Institute (PHTI) study has confirmed the clinical and economic benefits of virtual [...]
Time to Market and Patient Access to Oncology Medicines in Turkey
A study evaluated the accessibility of oncology medicines in Turkey, analyzing the time between global marketing authorizations and local availability, including reimbursement decisions, for 40 cancer drug-indication pairs authorized between 2015 and 2020. The study's results call for policy optimization to ensure timely access to cancer treatments while maintaining healthcare system viability.
Implications for Medical Affairs Teams in 2024 and Beyond
In 2024, medical affairs teams are pivotal in driving strategic impact within the pharmaceutical industry. They [...]
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
In this webinar, Dr. Joseph Zabinski discusses the digital phenotyping process and several concrete applications to demonstrate how AI can add value to analyses of the patient journey across the life sciences spectrum.
Vertex Pharmaceuticals Acquires Alpine Immune Sciences for $4.9 Billion
Vertex Pharmaceuticals is set to acquire Alpine Immune Sciences for $4.9 billion, expanding its portfolio into [...]
Sanofi to Close Kiadis Division Amid Pipeline Prioritization
Sanofi has decided to shut down Kiadis, a natural killer (NK) cell company acquired for $357 [...]
Congressional Concerns Over BGI’s Alleged Ties to Chinese Military
US lawmakers have raised alarms about BGI, a major Chinese genomics firm, allegedly attempting to skirt [...]
Bristol Myers Squibb Announces Layoffs at Mirati Therapeutics Following Acquisition
Bristol Myers Squibb (BMS) has initiated a significant workforce reduction at the headquarters of the recently [...]
Lenz Therapeutics Opts for Reverse Merger Ahead of Phase 3 Results
Lenz Therapeutics made its Nasdaq debut through a reverse merger, a strategic choice that CEO Eef [...]
